Boxberger F - Search Results

1

Bevacizumab plus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: results from a large German community-based observational cohort study.

Stein A, Petersen V, Schulze M, Seraphin J, Hoeffkes HG, Valdix AR, Schroeder J, Herrenberger J, Boxberger F, Leutgeb B, Hinke A, Kutscheidt A, Arnold D. Stein A, et al. Among authors: boxberger f. Acta Oncol. 2015 Feb;54(2):171-8. doi: 10.3109/0284186X.2014.961649. Epub 2014 Oct 13. Acta Oncol. 2015. PMID: 25307517

2

Palliative first-line therapy with weekly high-dose 5-fluorouracil and sodium folinic acid as a 24-hour infusion (AIO regimen) combined with weekly irinotecan in patients with metastatic adenocarcinoma of the stomach or esophagogastric junction followed by secondary metastatic resection after downsizing.

Koucky K, Wein A, Konturek PC, Albrecht H, Reulbach U, Männlein G, Wolff K, Ostermeier N, Busse D, Golcher H, Schildberg C, Janka R, Hohenberger W, Hahn EG, Siebler J, Neurath MF, Boxberger F. Koucky K, et al. Among authors: boxberger f. Med Sci Monit. 2011 May;17(5):CR248-58. doi: 10.12659/msm.881764. Med Sci Monit. 2011. PMID: 21525806 Free PMC article.

3

Palliative first-line treatment with weekly high-dose 5-fluorouracil as 24h-infusion and gemcitabine in metastatic pancreatic cancer (UICC IV).

Roehrig S, Wein A, Albrecht H, Konturek PC, Reulbach U, Männlein G, Wolff K, Ostermeier N, Hohenberger W, Hahn EG, Boxberger F. Roehrig S, et al. Among authors: boxberger f. Med Sci Monit. 2010 Mar;16(3):CR124-131. Med Sci Monit. 2010. PMID: 20190682 Clinical Trial.

4

Antiemetic prophylaxis and frequency of chemotherapy-induced nausea and vomiting in palliative first-line treatment of colorectal cancer patients: the Northern Bavarian IVOPAK I Project.

Koch S, Wein A, Siebler J, Boxberger F, Neurath MF, Harich HD, Hohenberger W, Dörje F. Koch S, et al. Among authors: boxberger f. Support Care Cancer. 2013 Sep;21(9):2395-402. doi: 10.1007/s00520-013-1801-z. Epub 2013 Apr 9. Support Care Cancer. 2013. PMID: 23568765

5

Weekly high-dose 5-fluorouracil as a 24-h infusion and sodium folinic acid (AIO regimen) plus irinotecan in patients with locally advanced nonresectable and metastatic adenocarcinoma or squamous cell carcinoma of the oesophagus: a phase II trial.

Wolff K, Wein A, Reulbach U, Männlein G, Brückl V, Meier C, Ostermeier N, Schwab SA, Horbach T, Hohenberger W, Hahn EG, Boxberger F. Wolff K, et al. Among authors: boxberger f. Anticancer Drugs. 2009 Mar;20(3):165-73. doi: 10.1097/CAD.0b013e32831f8ec9. Anticancer Drugs. 2009. PMID: 19125117 Clinical Trial.

6

Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial.

Boxberger F, Albrecht H, Konturek PC, Reulbach U, Maennlein G, Meyer T, Hohenberger W, Hahn EG, Wein A. Boxberger F, et al. Med Sci Monit. 2010 Feb;16(2):CR49-55. Med Sci Monit. 2010. PMID: 20110914 Clinical Trial.

7

[Palliative second-line treatment with oxaliplatin, gemcitabine and weekly high-dose 5-fluorouracil as 24-h infusion in patients with metastatic pancreatic adenocarcinoma].

Boxberger F, Happich K, Schirner I, Brueckl WM, Hohenberger W, Hahn EG, Wein A. Boxberger F, et al. Z Gastroenterol. 2002 Oct;40(10):881-4. doi: 10.1055/s-2002-35262. Z Gastroenterol. 2002. PMID: 12436355 German.

8

Relationship between microsatellite instability, response and survival in palliative patients with colorectal cancer undergoing first-line chemotherapy.

Brueckl WM, Moesch C, Brabletz T, Koebnick C, Riedel C, Jung A, Merkel S, Schaber S, Boxberger F, Kirchner T, Hohenberger W, Hahn EG, Wein A. Brueckl WM, et al. Among authors: boxberger f. Anticancer Res. 2003 Mar-Apr;23(2C):1773-7. Anticancer Res. 2003. PMID: 12820457 Clinical Trial.

9

Palliative chemotherapy with gemcitabine and weekly high-dose 5-fluorouracil as 24-h infusion in metastatic biliary tract and gall bladder adenocarcinomas.

Boxberger F, Jüngert B, Brueckl V, Brueckl WM, Hautmann M, Hohenberger W, Hahn EG, Wein A. Boxberger F, et al. Anticancer Drugs. 2003 Jan;14(1):87-90. doi: 10.1097/00001813-200301000-00012. Anticancer Drugs. 2003. PMID: 12544263

10

Palliative treatment of colorectal cancer in Germany: cost of care and quality of life.

Emmert M, Pohl-Dernick K, Wein A, Dörje F, Merkel S, Boxberger F, Männlein G, Joost R, Harich HD, Thiemann R, Lamberti C, Neurath MF, Hohenberger W, Schöffski O. Emmert M, et al. Among authors: boxberger f. Eur J Health Econ. 2013 Aug;14(4):629-38. doi: 10.1007/s10198-012-0408-5. Epub 2012 Jun 12. Eur J Health Econ. 2013. PMID: 22688440

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page